89bio, Inc.
IPO News: 89bio Launches 4.4mm Share IPO with $15-$17 Marketing Range
89bio, Inc.


Initial Filing Date:  10/11/19

Launch Date:  10/28/19

Price Range:  $15.00 - $17.00

Shares Offered (Pre-Shoe | mm):  4.4

Primary Shares (mm):  4.4

Secondary Shares (mm):  0.0

Amount Offered (@ Midpoint)(mm):  $70.0

% Secondary:  0.0%

Shares Outstanding (mm):  12.1

Market Value at Midpoint (mm):  $193.0

Offering as % of Market Value:  36.3%

Active Bookrunners:  BAML | SVB | RBC

Passive Bookrunner:  OPP

Major Holders:  OrbiMed | Longitude Venture Partners | RA Capital | Pontifax

Description:  89bio is a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases.

Note:  Emerging Growth Company

Reference Link:  S-1/A